Evidence map›Paper›PMID 37648007›Full record

ArticleBrain, behavior, and immunity2023

Microglia depletion ameliorates neuroinflammation, anxiety-like behavior, and cognitive deficits in a sex-specific manner in Rev-erbα knockout mice.

Ruizhuo Chen, Brandy N Routh, Jillian E Straetker, Cecily R Gibson, Aidan S Weitzner, Kiersten S Bell, Andrew D Gaudet, Laura K Fonken

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ruizhuo ChenDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA.
Brandy N RouthDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA; Institute for Neuroscience, The University of Texas at Austin, USA.
Jillian E StraetkerInstitute for Neuroscience, The University of Texas at Austin, USA.
Cecily R GibsonDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA; Institute for Neuroscience, The University of Texas at Austin, USA.
Aidan S WeitznerDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA.
Kiersten S BellDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA.
Andrew D GaudetInstitute for Neuroscience, The University of Texas at Austin, USA; Department of Psychology, The University of Texas at Austin, USA; Department of Neurology, Dell Medical School, The University of Texas at Austin, USA.
Laura K FonkenDivision of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, USA; Institute for Neuroscience, The University of Texas at Austin, USA. Electronic address: laura.fonken@austin.utexas.edu.
The University of Texas at Austin · USAustin College · US

Funding

Neurochemical & Behavioral Correlates of ETOH EffectsT32AA007471 · NIAAA · UNIVERSITY OF TEXAS AUSTIN · PI Kimberly Nixon · 1987 to 2026
$9.2M
Disrupted Circadian Regulation of Cell Migration at CNS-Immune Interfaces in Aging and Alzheimer's DiseaseR01AG078758 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI Laura K Fonken · 2022 to 2026
$2.9M
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approachR01AG062716 · NIA · UNIVERSITY OF TEXAS AT AUSTIN · PI FONKEN, LAURA K · 2020 to 2024
$2.4M
Circadian control of neuroinflammation after spinal cord injuryR01NS131806 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI Andrew David Gaudet · 2023 to 2026
$1.9M
NIAAA NIH HHS T32 AA007471NIA NIH HHS R01 AG062716NIA NIH HHS R01 AG078758NINDS NIH HHS R01 NS131806
6 · The paper itself

Abstract

The circadian system is an evolutionarily adaptive system that synchronizes biological and physiological activities within the body to the 24 h oscillations on Earth. At the molecular level, circadian clock proteins are transcriptional factors that regulate the rhythmic expression of genes involved in numerous physiological processes such as sleep, cognition, mood, and immune function. Environmental and genetic disruption of the circadian clock can lead to pathology. For example, global deletion of the circadian clock gene Rev-erbα (RKO) leads to hyperlocomotion, increased anxiety-like behaviors, and cognitive impairments in male mice; however, the mechanisms underlying behavioral changes remain unclear. Here we hypothesized that RKO alters microglia function leading to neuroinflammation and altered mood and cognition, and that microglia depletion can resolve neuroinflammation and restore behavior. We show that microglia depletion (CSF1R inhibitor, PLX5622) in 8-month-old RKO mice ameliorated hyperactivity, memory impairments, and anxiety/risky-like behaviors. RKO mice exhibited striking increases in expression of pro-inflammatory cytokines (e.g., IL-1β and IL-6). Surprisingly, these increases were only fully reversed by microglia depletion in the male but not female RKO hippocampus. In contrast, male RKO mice showed greater alterations in microglial morphology and phagocytic activity than females. In both sexes, microglia depletion reduced microglial branching and decreased CD68 production without altering astrogliosis. Taken together, we show that male and female RKO mice exhibit unique perturbations to the neuroimmune system, but microglia depletion is effective at rescuing aspects of behavioral changes in both sexes. These results demonstrate that microglia are involved in Rev-erbα-mediated changes in behavior and neuroinflammation.

Indexed as

Cognitive DysfunctionMicrogliaNuclear Receptor Subfamily 1, Group D, Member 1AnimalsAnxietyCircadian RhythmCognitionFemaleMaleMiceMice, KnockoutNeuroinflammatory DiseasesNr1d1 protein, mouseNuclear Receptor Subfamily 1, Group D, Member 1CircadianCognitionMicrogliaMoodNeuroinflammationRev-Erbα

Identifiers

PMID37648007
PMCPMC10788180
OpenAlexW4386227579

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.